Seok-Gu Kang

Department of Neurosurgery

https://orcid.org/0000-0001-5676-2037

EmailSEOKGU9@YUHS.AC

1442 Citations
21 h-Index

If you made any changes in Pure these will be visible here soon.

Fingerprint Fingerprint is based on mining the text of the person's scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

5 Similar Profiles

Glioblastoma Medicine & Life Sciences

Glioma Medicine & Life Sciences

temozolomide Medicine & Life Sciences

Mesenchymal Stromal Cells Medicine & Life Sciences

Neoplasms Medicine & Life Sciences

Neoplastic Stem Cells Medicine & Life Sciences

Survival Medicine & Life Sciences

Brain Neoplasms Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2000 2019

1442 Citations
21 h-Index
94 Article
3 Conference contribution
2 Letter
2 Review article

Clinical predictors of radiation-induced lymphopenia in patients receiving chemoradiation for glioblastoma: Clinical usefulness of intensity-modulated radiotherapy in the immuno-oncology era

Byun, H. K., Kim, N., Yoon, H. I., Kang, S-G., Kim, S., Cho, J., Baek, J. G., Chang, J. H. & Suh, C-O., 2019 Mar 27, In : Radiation Oncology. 14, 1, 51.

Research output: Contribution to journal › Article

Open Access

Intensity-Modulated Radiotherapy

Lymphopenia

Glioblastoma

temozolomide

Radiation

Combined treatment with 2′-hydroxycinnamaldehyde and temozolomide suppresses glioblastoma tumorspheres by decreasing stemness and invasiveness

Jeong, H., Park, J., Shim, J. K., Lee, J. E., Kim, N. H., Kim, H. S., Chang, J. H., Yook, J. I. & Kang, S-G., 2019 Jan 1, In : Journal of Neuro-Oncology.

Research output: Contribution to journal › Article

temozolomide

Glioblastoma

Epithelial-Mesenchymal Transition

Heterografts

Catenins

Effect of combined anti-PD-1 and temozolomide therapy in glioblastoma

Park, J., Kim, C. G., Shim, J. K., Kim, J. H., Lee, H., Lee, J. E., Kim, M. H., Haam, K., Jung, I., Park, S. H., Chang, J. H., Shin, E. C. & Kang, S-G., 2019 Jan 2, In : OncoImmunology. 8, 1, e1525243.

Research output: Contribution to journal › Article

temozolomide

Glioblastoma

Therapeutics

Neoplasms

Immunologic Memory

2 Citations (Scopus)

Immune checkpoint inhibitor-induced reinvigoration of tumor-infiltrating CD8+ T cells is determined by their differentiation status in glioblastoma

Park, J., Kwon, M., Kim, K. H., Kim, T. S., Hong, S. H., Kim, C. G., Kang, S-G., Moon, J. H., Kim, E. H., Park, S. H., Chang, J. H. & Shin, E. C., 2019 Apr 15, In : Clinical Cancer Research. 25, 8, p. 2549-2559 11 p.

Research output: Contribution to journal › Article

Glioblastoma

CTLA-4 Antigen

T-Lymphocytes

Tumor-Infiltrating Lymphocytes

Neoplasms

Re-evaluation of the diagnostic performance of ¹¹ C-methionine PET/CT according to the 2016 WHO classification of cerebral gliomas

Kim, D., Chun, J. H., Kim, S., Moon, J. H., Kang, S-G., Chang, J. H. & Yun, M., 2019 Jan 1, In : European Journal of Nuclear Medicine and Molecular Imaging.

Research output: Contribution to journal › Article

Isocitrate Dehydrogenase

Glioma

Seok-Gu Kang & Ho Young Lee

18/8/2

1 item of media coverage

Press/Media: Press / Media